Recent evidence indicates that adipose tissue macrophages and lymphocytes have a major role in the pathophysiology of obesity. The arterio-venous (A--V) difference technique has been used very effectively to understand adipose tissue metabolism in humans in vivo, and we set out to investigate whether it is possible to apply and use this technique to determine A --V differences for peripheral blood mononuclear cells (PBMCs) across human adipose tissue. We used flow-cytometric analysis of arterial blood and venous blood draining upper-(abdominal) and lower-body (femoral) adipose tissue depots in middle-aged volunteers (age 45±8 years, BMI 25.9±4.1 kg m À2 ). We determined A --V differences for various PBMCs. In basal conditions, there was evidence of modest retention of some PBMCs in adipose tissue, whereas the infusion of low-dose (physiological) adrenaline led to a marked release of many PBMCs (with little evidence of depot-specific differences). In addition to the demonstration that this approach is technically feasible, these results also indicate that physiological stimuli that change adrenaline concentrations and/or adipose tissue blood flow (such as physical activity) provoke the release of PBMCs from femoral and abdominal adipose depots.
INTRODUCTION
The arterio-venous (A --V) difference technique has been used for over 20 years to examine the physiology of adipose tissue in vivo. 1, 2 In the past few years, there has been much interest in the role of leukocytes in adipose tissue following the discovery that macrophages and lymphocytes are key drivers of adipose tissue inflammation. 3 --6 The picture is complex and some populations of macrophages and lymphocytes have beneficial rather than detrimental roles. 4, 5, 7 The contemporary view of adipose tissue inflammation depicts a scenario where peripheral blood mononuclear cells (PBMCs) are recruited by adipose tissue from the circulation. 8 Until now, there has been no attempt to make direct observations of this phenomenon in vivo. The application of the A --V technique could create opportunities to understand better the interactions between the immune system, adipose tissue inflammation and downstream pathologies. For example, it may be possible to compare between individuals (lean versus obese), to examine the effects of lifestyle (active versus sedentary) or to examine the effect of specific pharmacological agents on PBMC uptake and release from adipose tissue (including effects in specific adipose depots).
METHODS
In the present study, we used flow cytometry for the first time to examine PBMCs in arterial blood and venous blood draining two distinct adipose tissue depots (abdominal and femoral). Twelve volunteers were recruited (eight females; one of whom was postmenopausal). Mean±s.d. age, body mass index and waist:hip ratio were 45±8 years, 25.9±4.1 kg m À2 and 0.91±0.07, respectively.
All subjects provided written informed consent and the study was approved by the Milton Keynes NHS research ethics committee. Subjects reported in a fasting state and arterial blood was sampled from a catheter placed in the femoral artery. The superficial epigastric vein and great saphenous vein were cannulated to sample the effluent of subcutaneous abdominal and femoral adipose tissue, respectively. 9,10 Blood samples were collected simultaneously from all three sites before and immediately after a 60-min ramped adrenaline infusion (5, 15 and 25 ng min À1 per kg fat free mass; with each step lasting 20 min). Adrenaline was infused via a separate catheter placed in an antecubital vein. Adipose tissue blood flow (ATBF) was estimated using the 133 xenon-washout method as previously described.
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For each sample, 1 ml of whole blood was added to 9 ml of fixative and lysing solution (Becton Dickinson, Oxford, UK), mixed, and then incubated for 10 min at room temperature before storage at --80 1C. Subsequently, on the day of analysis, blood samples were brought to room temperature and washed in 40 ml phosphate-buffered saline (PBS). Following centrifugation, cells were counted and analyzed by flow cytometry. For analysis, 100 000 cells (in 100 ml PBS/0.5% bovine serum albumin, 2 mmol l À1 EDTA) were incubated (20 min, 4 1C) with antibodies (PerCP-CD45, PE-Cy7-CD14, APC-CD206, FITC-CD16, PE-CD3, APC-Cy7-CD8, FITC-CD4, APC-CD56; Becton Dickinson Bioscience, Le-Pont-de-Claix, France) or the appropriate isotype controls. After washing, the labeled cells were analyzed using a FACSCanto flow cytometer (BD Bioscience, Le-Pont-de-Claix, France) and the Becton Dickinson FACS Diva software. The PBMCs were identified through gating approaches as: total lymphocytes (CD45 þ /low SSC/low FSC),
The number of each cell population was calculated from the percentage of each cell type and the number of cells per ml of blood.
Paired t-tests were used to compare venous and arterial leukocyte counts and A --V differences in basal conditions and after adrenaline infusion. The very small veins that drain adipose tissue are challenging to cannulate and patency is difficult to maintain. As a result, there are unequal samples and comparisons (see figure legends) . Significance is presented as *Po0.05 and large effect sizes (that is, 40.8) are also indicated where appropriate and according to convention. 12 
RESULTS AND DISCUSSION
In basal resting conditions there was modest retention of some PBMCs in adipose tissue although this was only statistically significant for monocytes and CD16-monocytes in femoral adipose (Supplementary Tables 1 and 2 ). In contrast, the infusion of a physiological dose of adrenaline led to a marked release of PBMCs from both femoral and abdominal adipose depots; with the exception of cytotoxic T cells, NKT cells and B lymphocytes from abdominal adipose (Figures 1 and 2) .
As far as we are aware, these are the first observations of their kind. No studies have examined PBMCs in arterial blood or made A --V comparisons for any leukocyte population across any specific tissue (including adipose tissue). An inherent strength of the A --V technique is that it isolates a specific tissue and determines the net exchange of a given substance or, in this case, cell type; although issues such as lag time, variable blood flow and the precise location of catheters are all important considerations when interpreting data. 2 Indeed, before we are in a position to determine net flux for each cell type with confidence we need further information on factors such as steady-state and lag time. 2 Although the novelty of these findings make it difficult to draw direct comparisons with previous studies, these preliminary observations indicate that it is possible to use the A --V technique to examine the net movement of defined cells in and out of specific adipose depots in humans. The effect of adrenaline infusion on adipose tissue A --V differences might be due to the effect of adrenaline on demargination of cells from the endothelium. 13 --15 However, there was also an approximate doubling of ATBF with adrenaline and this could independently cause the mobilization of looselyadhered cells (ATBF increased from 3.2 ± 0.6 and 3.7 ± 0.2 to 6.2±1.3 and 6.0±0.9 ml min À1 per 100 g after adrenaline infusion in femoral and abdominal adipose tissue, respectively; Po0.05). It seems unlikely that many of these cells were mobilized from the interstitium around adipocytes given the relatively short time frame. Longer-duration infusion studies may be revealing and it may be possible to directly assess whether different agents have the capacity to mobilize specific leukocytes from defined adipose depots. It is noteworthy that abdominal and femoral ATBF tend to respond differently to adrenergic stimulation, 16 but in the present study no depot-related differences in ATBF were observed. This discrepancy may be related to heterogeneity in our subject population (for example, age, BMI, sex). Nevertheless, it is tempting to speculate that ATBF may be a key factor influencing adipose tissue leukocyte fluxes and potential differences between depots. Additional studies will be necessary to determine the role of ATBF in leukocyte flux.
It seems reasonable to assume that PBMCs released either in direct response to adrenaline or secondary to increased ATBF are no longer available to migrate into adipose tissue and take part in localized inflammatory processes (unless PBMC retention rose after adrenaline infusion ended). Such rebound effects not withstanding, physical activity is a major stimulus for adrenaline secretion and increased ATBF; 17 and thus would be anticipated to remove PBMCs from adipose tissue in vivo. Even very low intensity physical activity functions as a powerful stimulus. 17, 18 Whether the endocrine and adipose tissue haemodynamic response to regular physical activity influences adipose tissue leukocyte balance or exchange is an intriguing question. Interestingly, ATBF in obesity is less responsive to adrenaline and physical activity 19, 20 and this may provide one explanation for the accumulation of cells in this tissue (that is, they might 'hang around' in the vasculature of obese adipose tissue and this might make them more likely to participate in immune-related processes).
These novel observations open up potential opportunities but there are some limitations. The initial sample size was reduced by the technical difficulty in conducting these studies. Furthermore, although venous samples were taken from well-established sites in upper-and lower-body adipose tissue, we know little about the precise location relative to specific anatomical landmarks (for example, lymph nodes). We should also bear in mind that the adrenaline infusion was physiological but relatively short-term; and the balance of some cells may have changed after the observation period. It is possible that each leukocyte population has a different (unknown) time course in response to adrenaline.
CONCLUSION
In this short communication, we confirm that it is possible to determine A --V differences for specific PBMCs across adipose tissue in humans. Furthermore, our findings suggest that either haemodynamic changes in blood flow or direct activation from adrenaline provokes the release of various PBMC populations from both upper-and lower-body adipose tissue depots. Further research using this technique will shed light on differences in adipose tissue leukocyte exchange between people of variable adiposity and health status; as well as the response to changes in behavior (for example, caloric restriction and/or increased physical activity) and pharmacological treatment(s).
